ORKA
Oruka Therapeutics
$91.65
+$0.15 (+0.16%)Sep 10, 2026
Key metrics
The numbers that frame ORKA today
- Market cap
- $6.07B
- P/E (TTM)
- -45.7
- EV / FCF
- -57.4
- ROIC
- -25.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $14.67
- 52wk High
- $115.51
Growth
Revenue and earnings trend for ORKA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ORKA
Is Oruka Therapeutics a good buy?
Hold. Oruka Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks strong, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Oruka Therapeutics is selling at a high price.
What is the market capitalization of ORKA?
Oruka Therapeutics's market capitalization is $6.07B.
What is the P/E ratio for ORKA stock?
Oruka Therapeutics's current P/E ratio is -45.7.
What is the 52-week high for ORKA stock?
The 52-week high for Oruka Therapeutics is $115.51. The current close of $91.65 is 20.7% below that high.
What is the 52-week low for ORKA stock?
The 52-week low for Oruka Therapeutics is $14.67. The current close of $91.65 is 525% above that low.
Does ORKA stock pay dividends?
Oruka Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ORKA?
Oruka Therapeutics's Debt / Equity ratio is 0.